(1996): Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study
From insulin to semaglutide, and from BPC-157 to GHK-Cu, peptides are reshaping how we think about ageing and optimising health
Reported side effects are typically mild and transient: BPC-157: Nausea (rare), mild fatigue in the first week, minor injection site redness TB-500: Mild lethargy during the loading phase, transient head rush immediately after injection, injection site discomfort Combined stack: No documented synergistic toxicity in preclinical or clinical observational data The more significant risks relate to sourcing and administration rather than the peptides themselves
This is a sign of a dull needle or poor technique and is a form of contamination
For example, the active agents loaded into liposomes are mixed with a chitosan-glycerophosphate composition
Memberships Get rewarded for feeling your best